The company is poised to reduce patient intake
waitlist times by over 80% to less than 30 days.
MCLEAN,
Va., Oct. 24, 2024 /PRNewswire/ -- Appian
(Nasdaq: APPN) today announced Acclaim Autism, a leading
multi-state behavioral healthcare company based in Philadelphia, is using Appian's
private AI capabilities to simplify and accelerate its patient
onboarding process. Acclaim Autism specializes in providing
evidence-based therapy services to children with Autism Spectrum
Disorder (ASD), offering care in homes, schools, and community
settings. Acclaim Autism is committed to improving operational
efficiency, particularly in its patient intake process. Appian and
Appian's systems integration partner, Ignyte, are proud to support
Acclaim Autism in this mission.
The behavioral health industry faces unique challenges,
including limited funding and complex patient intake processes.
These obstacles often lead to long wait lists, with families
experiencing delays of three to six months before receiving care.
Acclaim Autism's leadership recognized the need for an innovative
solution to expedite their intake process, while ensuring
compliance with strict data privacy policies and HIPAA regulations.
This led them to partner with Appian and Ignyte to safely and
compliantly implement generative AI in their existing document
processing workflow.
The Appian AI solution streamlines the processing of
unstructured medical documents, such as diagnosis documents, which
are crucial in the patient onboarding process. While traditional
extraction methods struggled to effectively process this dense,
free-text data, with Appian's private AI, Acclaim Autism was able
to automate the extraction of essential patient information,
including date of birth, diagnosis details like DSM-5 codes, and
doctor information. This AI solution enables a faster, more
accurate intake process while ensuring HIPAA compliance and
safeguarding patient privacy.
"Our collaboration with Appian on developing the autism
diagnosis generative AI extraction application will be a
game-changer for Acclaim Autism," said Ryan
Cox, VP at Acclaim Autism. "This is a groundbreaking
solution that will significantly improve the accuracy of our data
extractions while ensuring that our intake staff and clinicians
remain integral to the process. It's a perfect blend of
cutting-edge technology and human expertise, allowing us to deliver
even more precise and personalized care and treatment planning to
our clients."
Since deploying the AI-enhanced solution, Acclaim Autism has
achieved a 95% accuracy rate in data extraction. The automation has
also reduced staff workload, allowing them to focus on higher value
tasks. The company is on track to reduce patient intake wait times
by over 80% to just one month, significantly improving timely
access to care for families. In existing service areas, eligible
clients can expect intake times of less than ten days.
"We're excited to see Acclaim Autism leverage Appian to make a
real difference in the lives of the families they serve," said
Sanat Joshi, Executive Vice
President, Product & Solutions, Appian. "Generative AI is a
powerful tool that not only improves operational efficiency but
also helps organizations provide more personalized and timely
patient care."
Learn more about how Acclaim Autism is using Appian's generative
AI.
About Acclaim Autism
Acclaim Autism specializes in comprehensive home-based ABA
Therapy programs. With a focus on families, the company strives to
be the provider of choice in the Greater
Philadelphia area. Acclaim Autism's goal is to provide the
best ABA therapy and train the best therapists in the region.
About Appian
Appian is a software company that orchestrates business
processes. The Appian Platform empowers leaders to design,
automate, and optimize important processes from start to finish.
With our industry-leading platform and commitment to customer
success, Appian is trusted by top organizations to drive
transformational process change. For more information, visit
appian.com. [Nasdaq: APPN]
Follow Appian: LinkedIn, X (Twitter)
View original content to download
multimedia:https://www.prnewswire.com/news-releases/acclaim-autism-enhances-patient-intake-efficiency-with-appians-generative-ai-ensuring-compliance-302285954.html
SOURCE Appian
